Achondroplasia is a hereditary bone disorder that results in disproportionate short stature. The disorder results from a mutation in the FGFR3 gene, leading to abnormal cartilage and bone development. It is characterised by short hands and legs, a large head, prominent forehead, flat face, short fingers, and spinal or lower limb deformities. Most individuals with the condition have normal intelligence.
Achondroplasia is a lifelong genetic condition, but proper medical supervision can help manage it and reduce complications. Management may involve a team of specialists comprising a geneticist, pediatrician, orthopedist, neurosurgeon, cardiologist, ENT specialist, physiotherapist, and others depending upon the patient’s condition.
Currently, there is no cure for achondroplasia, but it is possible to avoid, determine, or cure complications by conducting surgeries when necessary. Constant monitoring is essential in the early years of patients’ lives because they may develop complications involving the foramen magnum, spine, breathing, auditory function, and movement that require intervention.
For instance, the compression of the craniocervical junction becomes complicated in infancy, while spinal stenosis can be problematic in childhood and adulthood. Timely treatment helps detect complications early, monitor growth, manage skeletal and neurological concerns, support mobility, provide rehabilitation, and promote greater independence and quality of life.
The features can vary between individuals. Common characteristics include:
Not every person with achondroplasia develops all of these complications. Regular medical assessment helps determine appropriate monitoring or treatment.
Causes
Risk Factors
Recent advances in achondroplasia treatment include growth-modulating therapies that target the FGFR3 pathway involved in abnormal bone growth. A CNP analogue can increase growth velocity in eligible children with open growth plates.
Newer therapies such as navepegritide are also being studied and approved in certain countries. Alongside medical therapies, advances in genetic testing, imaging, orthopedic surgery, neurosurgical techniques, and rehabilitation are improving the evaluation and management of achondroplasia and its complications.
Growth-Modulating Therapy: Eligible children with open growth plates may be considered for growth-modulating treatment such as vosoritide or other approved therapies, depending on local regulatory approval and clinical suitability.
Bow Leg Correction : Surgical corrections usually consist of osteotomy (bone cutting and realignment). The bones are fixed internally with plates and screws or externally with an external fixator. For younger patients, surgeons may sometimes perform guided growth surgery. Surgery is done under general anesthesia.
Cost Start From 3500Explore Options
Spinal Decompression and Fixation : Patients with symptomatic craniocervical compression or clinically significant spinal stenosis may require neurosurgical evaluation. Spinal decompression may be recommended when spinal canal stenosis causes neurological symptoms.
Cost Start From 6500Explore Options
Limb Lengthening Surgery : Limb-lengthening procedures are an elective option for selected individuals and are not required for everyone with achondroplasia. They involve prolonged treatment and can have significant complications.
Cost Start From 6500Explore Options
MediRehab (chain of Rehab centres - Part of MediGence) provides comprehensive rehabilitation services designed to support Achondroplasia patients in India. These services include:









Faridabad, India
Marengo Asia Hospitals, located in Faridabad, is a multispecialty, state-of-the-art, and patient-friendly facility that combines the greatest services available in the healthcare segment. With 325 beds now, the hospital can accommodate up to 550 beds. It has first-rate medical facilities including a Critical Care Medicine department for patients with life-threatening conditions. Furthermore, our highly skilled medical staff and cutting-edge software system make us the perfect facility for patients from various backgrounds. We always aim to exceed expectations and are always looking for ways to boost our performance.

Delhi, India
BLK-Max Super Speciality Hospital, located in New Delhi, is the leading best-in-class healthcare institution in India, providing tertiary and quaternary care. 650 + beds including 162 critical care beds, 22 OTs with 1,500+ clinical professionals allied to health are at the hospital's disposal. JCI, NABH, and NABL accredited. The hospitals are a leader in transplants, cancer care, and robotic surgery education and implementation. Established in1959 by Dr. B.L. Kapur, the hospital combines state-of-the-art technology with patient-centric values including compassion, efficiency, and consistency.

Gurgaon, India
Fortis Healthcare Limited stands as one of India's largest integrated healthcare providers, managing 33 hospitals across 11 states and operating more than 5,700 beds and 400 diagnostic labs. Four of our hospitals are accredited by JCI and 26 by NABH. With a workforce of over 12,500 healthcare professionals, we combine clinical excellence, a patient-focused approach, and innovation to provide high-quality, affordable, and compassionate healthcare to patients in India.
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome